https://acuity.news/technology/wave-neuroscience-mert-fda-clearance-adult-ptsd-cpt-code-2026/Acuity Newsen2026-09-08T11:55:00-06:00Wave Neuroscience’s MeRT Gains FDA Clearance for Adult PTSD on the First Sham-Controlled Trial in the Category. The 510(k) Summary Details the Trial Results, the Safety Profile, and the Reimbursement Path Ahead. https://acuity.news/regulation/iacc-2026-2028-autism-strategic-plan-profound-autism-nih-funding/Acuity Newsen2026-09-08T06:53:31-06:00IACC Adopts 2026-2028 Autism Strategic Plan With a $747.4 Million Funding Recommendation. NIH Named Profound Autism a Highlighted Funding Topic the Same Morning, and HRSA Filed 41 Corrections.